XOMA (XOMAP) News Today → AI finds its first serious application (From Wall Street Star) (Ad) Free XOMAP Stock Alerts $25.03 -0.03 (-0.12%) (As of 11:47 AM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsDividendFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsDividendFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineXOMA Co. (NASDAQ:XOMAP) Short Interest Down 22.2% in Aprilamericanbankingnews.com - April 28 at 1:34 AMXOMA Corporation 8.625% Series A Cumulative Perpetual Preferred Stockthestreet.com - April 17 at 9:54 AMXOMA Corp - 8.375% DP PFD B declares $0.5234 dividendmsn.com - March 21 at 9:32 AMAdhoc: Kuros Biosciences AG: Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023finanznachrichten.de - March 13 at 5:43 PMAnalysts Conflicted on These Healthcare Names: Xoma (XOMA) and Lexicon Pharmaceuticals (LXRX)markets.businessinsider.com - March 11 at 6:26 PMCox Communications wins order overturning $1 billion US copyright verdictmsn.com - February 23 at 5:15 PMXOMA Jun 2024 20.000 putfinance.yahoo.com - February 17 at 7:14 AMXOMA Sep 2024 12.500 putfinance.yahoo.com - February 17 at 7:14 AMStrategic Acquisitions and Royalty Income Streams Justify Buy Rating for Xomamarkets.businessinsider.com - February 16 at 9:13 PMKinnate Biopharma Shares Rise on XOMA Acquisitionmarketwatch.com - February 16 at 11:12 AMKinnate Biopharma To Be Acquired By XOMA In Cash Deal; Stock Gainsmarkets.businessinsider.com - February 16 at 11:12 AMmarketbeat.com - February 16 at 7:59 AMXOMA Corporation: XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA Acquisitionfinanznachrichten.de - January 18 at 2:06 PMXOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisitionfinance.yahoo.com - January 18 at 8:57 AMXOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® Acquisitionfinance.yahoo.com - January 18 at 8:57 AMXOMA Names Hughes Permanent CEO; Wyszomierski Becomes Chairmanmarketwatch.com - January 8 at 8:08 AMXOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of Directorsfinance.yahoo.com - January 8 at 8:08 AMXOMA Stock (NASDAQ:XOMA) Dividends: History, Yield and Datesbenzinga.com - December 22 at 5:35 PMXOMA Corp XOMAmorningstar.com - November 11 at 12:52 PMXOMA GAAP EPS of -$0.60 misses by $0.12, revenue of $0.83M misses by $0.36Mmsn.com - November 7 at 9:23 AMObsEva SA: Organon Returns Ebopiprant to XOMAfinanznachrichten.de - October 27 at 5:32 PMOrganon Returns Ebopiprant to XOMAfinance.yahoo.com - October 27 at 5:32 PMXoma (XOMA) Moves 7.7% Higher: Will This Strength Last?msn.com - September 18 at 2:20 PMXOMA Corpmoney.usnews.com - September 15 at 12:33 PMH.C. Wainwright Sticks to Their Buy Rating for Xoma (XOMA)markets.businessinsider.com - September 13 at 7:46 AMOwning 35% shares,institutional owners seem interested in XOMA Corporation (NASDAQ:XOMA),finance.yahoo.com - August 13 at 3:52 PMXOMA Reports Second Quarter 2023 Financial Results and Provides Update on its Royalty Monetization Strategyfinance.yahoo.com - August 8 at 7:40 AM Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMAP and its competitors with MarketBeat's FREE daily newsletter. Email Address Healthcare Takes A Big Step Forward With The Help Of AI (Ad)The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+. Click here to see why this small company is trusted by the Mayo Clinic XOMAP Media Mentions By Week XOMAP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. XOMAP News Sentiment▼0.480.34▲Average Medical News Sentiment XOMAP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. XOMAP Articles This Week▼20▲XOMAP Articles Average Week Get XOMA News Delivered to You Automatically Sign up to receive the latest news and ratings for XOMAP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Alpha Tau Medical News Artelo Biosciences News BriaCell Therapeutics News eFFECTOR Therapeutics News Fortress Biotech News GeoVax Labs News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:XOMAP) was last updated on 4/30/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportProtect Your Bank Account Before It’s Too LateWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaNvidia CEO Says It Will Be “the Next Revolution” Beyond AIBanyan Hill PublishingHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
